SpiraTec AG
Maximilian Schell is an Engineer specializing in Industrial Engineering and Design at SpiraTec AG since March 2024. Prior experience includes a role as a Specialist in Bioprocess Development (Bioanalytics) at R-Pharm Germany GmbH, where Maximilian established and validated bioanalytical methods, primarily focusing on capillary electrophoresis for monoclonal antibody analysis. Previous positions involve contributions to analytical development at Boehringer Ingelheim, where Maximilian conducted research for a master's thesis on the quantification and spectral analysis of antibodies using FTIR technology, and performed hands-on analysis of monoclonal antibodies using various spectroscopic methods. Maximilian also gained experience as a working student at R-Pharm Germany GmbH in the Product and Process Development Center, handling validation reports and analyses of monoclonal antibodies. An educational background includes a Master of Science in Industrial Biotechnology from Ulm University and a Bachelor of Science in Industrial Biotechnology from Fachhochschule Biberach.
This person is not in any teams
SpiraTec AG
As a globally active company for industrial engineering and solutions in the process industry, our core competencies lie in the planning, construction and support of process engineering production plants. As the SpiraTec Group, we are the experts when it comes to industrial planning and high-tech solutions in the areas of digital transformation, engineering, robotics services, automation and IT in the industrial environment, together with over 600 employees in Germany, Italy, Austria and the USA at more than 30 locations. With our comprehensive portfolio ranging from consulting, planning, application development and implementation to commissioning and optimization of running production plants, SpiraTec guarantees interface-optimized handling of national and international projects.